Apathy and associated factors in Mexican patients with Parkinson's disease
- PMID: 24306058
- DOI: 10.1007/s10072-013-1591-6
Apathy and associated factors in Mexican patients with Parkinson's disease
Abstract
Apathy is one of the most common behavioral disturbances in Parkinson's disease (PD) with a reported prevalence of 17-51 %. Apathy has been associated with depression, cognitive deficits, and poor quality of life. The objective of this study was to determine the prevalence of apathy in Mexican subjects with PD and its correlation with clinical and demographic characteristics. A cross-sectional, descriptive, and analytic study was carried out. Consecutive subjects with PD attending the National Institute of Neurology and Neurosurgery in Mexico City were included. Demographic and other relevant clinical data were collected. The Apathy Scale was applied to all subjects. A cut-off score of ≥ 14 was used. A total of 241 non-demented patients (52.7 % male) were included. Apathy was found in 43 % of subjects. Lower body mass index, older age of PD onset, cognitive decline and disease severity were all related to apathy. The use of dopamine agonists or rasagiline was more common in patients with low apathy scores. Our results show that the prevalence of apathy in Mexican subjects with PD is similar to other reports.
Similar articles
-
The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's disease in Mexico.Neuropsychiatry Neuropsychol Behav Neurol. 2002 Jun;15(2):99-105. Neuropsychiatry Neuropsychol Behav Neurol. 2002. PMID: 12050472
-
Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472. JAMA Neurol. 2015. PMID: 25420207 Clinical Trial.
-
Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients.Drugs Aging. 2015 May;32(5):401-7. doi: 10.1007/s40266-015-0264-y. Drugs Aging. 2015. PMID: 25941103
-
[Comorbid states in Parkinson's disease: an effect of MAO-B inhibitors].Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(4):90-99. doi: 10.17116/jnevro20161164190-99. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 27386592 Review. Russian.
-
[Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].Rev Neurol. 2013 Jan 1;56(1):25-34. Rev Neurol. 2013. PMID: 23250679 Review. Spanish.
Cited by
-
Co-occurrence of apathy and impulse control disorders in Parkinson disease.Neurology. 2020 Nov 17;95(20):e2769-e2780. doi: 10.1212/WNL.0000000000010965. Epub 2020 Oct 1. Neurology. 2020. PMID: 33004605 Free PMC article.
-
Neuropsychiatric symptoms in untreated Parkinson's disease.Neuropsychiatr Dis Treat. 2017 Mar 16;13:815-826. doi: 10.2147/NDT.S130997. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 28352181 Free PMC article. Review.
-
Apathy-Related Symptoms Appear Early in Parkinson's Disease.Healthcare (Basel). 2022 Jan 4;10(1):91. doi: 10.3390/healthcare10010091. Healthcare (Basel). 2022. PMID: 35052255 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical